Analysts have maintained their price target for Calumet at $19.05. They cite only minor adjustments to discount rate and valuation assumptions that do not materially alter their outlook for the company.
What's in the News
- Calumet received notification from the U.S. Environmental Protection Agency (EPA) confirming full or partial exemptions for every small refinery petition filed between 2019 and 2024 (Key Developments).
- The EPA's decision will significantly reduce Calumet's accrued Renewable Identification Number (RIN) liability from 396 million to 89 million RINs (Key Developments).
- Of the 89 million RINs now accrued, 57 million are from 2022 and 2023 vintage, and 32 million are from 2024 (Key Developments).
Valuation Changes
- Consensus Analyst Price Target remains unchanged at $19.05.
- Discount Rate has decreased modestly, moving from 9.54% to 9.26%.
- Revenue Growth projection is stable at approximately 8.00%.
- Net Profit Margin estimate is effectively unchanged, remaining near 0.79%.
- Future P/E ratio has declined marginally, from 55.33x to 54.91x.
Have other thoughts on Calumet?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.